- Rank15
- Previous Rank14
- CEOJohn H. Hammergren
- Address1 Post St., San Francisco, CA 94104
- Websitewww.mckesson.com
The nation’s largest drug distributor dropped one spot on this year’s list after a decline in warehouse sales resulted in a slight revenue dip. McKesson’s profits also slipped last year — down 4.6% to $1.3 billion — but the company hopes to improve its earnings and reach through its purchase of Germany’s Celesio, one of Europe’s top drug wholesalers. The company also recently drew the ire of activist investors upset over CEO John Hammergren’s record-setting $159 million pension benefit. The company leader responded to the complaints by agreeing to cut $45 million from the lump-sum compensation.
Key Financials
| $ Millions | % change | |
|---|---|---|
| Revenues | 122,455 | -0.2 |
| Profits | 1338 | -4.6 |
| Total Assets | 34,786 | - |
| Total Shareholder Equity | 7,070 | - |
| Market Value (on March 31, 2014) | 40,633 | - |
Profit as a % of
| Sales | 1.1 |
| Assets | 3.8 |
| Stockholders' Equity | 18.9 |
Earnings Per Share
| Earnings Per Share ($) | 5.59 |
| EPS % Change (from 2012) | - |
| EPS % Change (5 year) | 11 |
| EPS % Change (10 year) | 11.5 |
Total Return to Investors
| Total Return to Investors | 67.7 |
| Total Return to Investors (5 year, annualized) | 34.3 |
| Total Return to Investors (10 year, annualized) | 18.4 |